Alps Advisors Inc Ultragenyx Pharmaceutical Inc. Transaction History

Alps Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$36.99 - $48.71 $46,792 - $61,618	-1,265 Reduced 2.66%	46,259 $1.85 Million
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $1.6 Million - $2.2 Million	47,524 New	47,524 $2.2 Million
Q4 2017 Feb 05, 2018	SELL	$43.54 - $57.32 $1.82 Million - $2.4 Million	-41,814 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$49.79 - $66.32 $2.08 Million - $2.77 Million	41,814	41,814 $2.23 Million

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.